Table 1: Baseline characteristics of
study population.
Parameters |
Overall
patients with Atrial Fibrillation (n
=32)(%) |
Age
(Mean±SD) years |
59.93±13.81
|
Female |
15 (46.9) |
Male |
17
(53.1) |
Body
Mass Index ( Mean) (Kg/m2) |
24.25 |
Medical
History |
|
Chest
Pain |
3
(9.3) |
Palpitations |
6
(18.8) |
Shortness
of Breath |
3
(9.3) |
Hypertension |
5
(15.6) |
Smoker |
3
(9.3) |
COVID-19
patients |
2
(6.2) |
Diabetic |
3
(9.3) |
Coronary
Artery Disease |
7
(21.8) |
History
of Medications |
|
Subjects
on Anti-Coagulant Drugs |
16
(50) |
Subjects
on Diuretics Drugs |
12
(37.5) |
Subjects
on Antacid |
9
(28.1) |
Subjects
on Anti-Hypertensive Drugs |
13
(40.6) |
Subjects
on Anti-Anginal Drugs |
3
(9.3) |
Subjects
on Anti-Hyperlipidemic Drugs |
8
(25) |
Subjects
on Hyperglycemic Drugs |
3
(9.3) |